Plunkett Research Online: Audentes Therapeutics Inc

AUDENTES THERAPEUTICS INC (Subsidiary) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Audentes Therapeutics, Inc. is a biotechnology company committed to the development and commercialization of innovative adeno-associated viral vector (AAV)-based genetic medicines. In addition to its gene therapy portfolio targeting serious rare neuromuscular diseases, Audentes leverages Astellas’ .....


AUDENTES THERAPEUTICS INC

Ticker: Subsidiary
Exchange:
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 415-818-1001
Fax:
Address: 600 California St., 17/Fl
San Francisco, CA 94108 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:
Parent Company: Astellas Pharma Inc

Contacts Description

Natalie Holles CEO
Thomas Soloway CFO/Chief Accounting Officer/Executive VP
See More
Audentes Therapeutics, Inc. is a biotechnology company committed to the development and commercialization of innovative adeno-associated viral vector (AAV)-based genetic medicines. In addition to its gene therapy portfolio targeting serious rare neuromuscular diseases, Audentes leverages Astellas’ .....See More See More

$USD, In whole numbers 2019 2018 2017 2016 2015 2014 2013
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture